N. Chevalier et al., Trypanosoma brucei contains a 2,3-bisphosphoglycerate independent phosphoglycerate mutase, EUR J BIOCH, 267(5), 2000, pp. 1464-1472
Assays of phosphoglycerate mutase (PGAM) activity in lysates of bloodstream
form Trypanosoma brucei appeared not to require exogenous 2,3-bisphosphogl
ycerate, thus suggesting that this protist contains an enzyme belonging to
the class of cofactor-independent PGAMs. A gene encoding a polypeptide with
motifs characteristic for this class of enzymes was cloned. The predicted
T. brucei PGAM polypeptide contains 549 amino acids, with M-r 60 557 and pI
5.5. Comparison with 15 cofactor-independent PGAM sequences available in d
atabases showed that the amino-acid sequence of the trypanosome enzyme has
59-62% identity with plant PGAMs and 29-35% with eubacterial enzymes. A low
28% identity was observed with the only available invertebrate sequence. T
he trypanosome enzyme has been expressed in Escherichia coli, purified to h
omogeneity and subjected to preliminary kinetic analysis. Previous studies
have shown that cofactor-dependent and -independent PGAMs are not homologou
s. It has been inferred that the cofactor-independent PGAMs are in fact hom
ologous to a family of metalloenzymes containing alkaline phosphatases and
sulphatases. Prediction of the secondary structure of T. brucei PGAM and th
reading the sequence into the known crystal structure of E. coli alkaline p
hosphatase (AP) confirmed this homology, despite the very low sequence iden
tity. Generally, a good match between predicted (PGAM) and actual (AP) seco
ndary structure elements was observed. In contrast to trypanosomes, glycoly
sis in all vertebrates involves a cofactor-dependent PGAM. The presence of
distinct nonhomologous PGAMs in the parasite and its human host offers grea
t potential for the design of selective inhibitors which could form leads f
or new trypanocidal drugs.